All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Calgizzarin (S100A11): a novel inflammatory mediator associated with disease activity of rheumatoid arthritis

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F17%3A10363893" target="_blank" >RIV/00216208:11110/17:10363893 - isvavai.cz</a>

  • Alternative codes found

    RIV/00023728:_____/17:N0000023

  • Result on the web

    <a href="http://dx.doi.org/10.1186/s13075-017-1288-y" target="_blank" >http://dx.doi.org/10.1186/s13075-017-1288-y</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1186/s13075-017-1288-y" target="_blank" >10.1186/s13075-017-1288-y</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Calgizzarin (S100A11): a novel inflammatory mediator associated with disease activity of rheumatoid arthritis

  • Original language description

    Background: Calgizzarin (S100A11) is a member of the S100 protein family that acts in different tumors by regulating a number of biologic functions. Recent data suggest its association with low-grade inflammation in osteoarthritis (OA). The aim of our study is to compare S100A11 expression in the synovial tissues, synovial fluid and serum of patients with rheumatoid arthritis (RA) and osteoarthritis (OA) and to characterize the potential association between S100A11 and disease activity. Methods: S100A11 protein expression was detected in synovial tissue from patients with RA (n = 6) and patients with OA (n = 6) by immunohistochemistry and immunofluorescence. Serum and synovial fluid S100A11 levels were measured by ELISA in patients with RA (n = 40) and patients with OA (n = 34). Disease activity scores in 28 joints based on C-reactive protein (DAS28-CRP) were used to assess disease activity. Cytokine content in peripheral blood mononuclear cells (PBMCs), synovial fibroblasts (SFs) and synovial fluid was analysed by ELISA, western blotting or cytometric bead array. Conclusions: Our data provide the first evidence of S100A11 up-regulation and its association with inflammation and disease activity in patients with RA.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30226 - Rheumatology

Result continuities

  • Project

    <a href="/en/project/NV15-34065A" target="_blank" >NV15-34065A: Role of S100A11 (calgizzarin) in the pathogenesis of rheumatoid arthritis</a><br>

  • Continuities

    V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Others

  • Publication year

    2017

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Arthritis Research &amp; Therapy

  • ISSN

    1478-6354

  • e-ISSN

  • Volume of the periodical

    19

  • Issue of the periodical within the volume

    April

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    10

  • Pages from-to

  • UT code for WoS article

    000401177500003

  • EID of the result in the Scopus database

    2-s2.0-85018293040